gvtcx

PHE_Scientific_ Provision of Liaison XL associated assays, reagents and consumables

Public Health England Published 5 Aug 2020 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£1,150,000
Statuscomplete
Category (CPV) 38434000 +1 more
Deadline9 Mar 2020
Contract start10 Mar 2020
Contract end31 Mar 2021
Procedureselective
SME suitableYes
OCIDocds-b5fd17-7c324218-6c9f-441e-a59e-b7c57667c32c

Awards (2)

This procurement was awarded to 1 suppliers. Values shown are per-award; the notice total is £1,150,000.

SupplierValueDateStatus
DiaSorin Limited £1,150,000 9 Mar 2020 active
DiaSorin Limited £1,100,000 9 Mar 2020 active

description

Public Health England (PHE) has awarded a contract to DiaSorin for the provision of LIAISON XL associated assays, reagents and consumables used by all PHE sites.

PHE's organisational structure is currently undergoing a transformation, in addition prioritisation of the response to COVID-19 pandemic, this contract covers all DiaSorin LIAISON products currently used by PHE's Laboratories.

The contract was executed via a direct award under Lot 1(Diagnostics) of the PHE Microbiology Framework and will run until 31.03.2021 with an option to extend for 3 further periods of 12 months each.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
5 Aug 2020 Award (award) · cd7e2937-ea9f-48ea-909a-d2baefb24545-374419

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.